Lazard Capital Initiates Coverage on ONYX Pharmaceuticals (ONXX) with a Buy
Tweet Send to a FriendGet Alerts ONXX Hot Sheet
Price: $95.65 +0.31%
Rating Summary:
20 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
20 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade ONXX Now!
Lazard Capital initiates coverage on ONYX Pharmaceuticals (Nasdaq: ONXX) with a Buy rating. PT $35.
To see all the upgrades/downgrades on shares of ONXX, visit our Analyst Ratings page.
Shares finished trading at $27.68 and the 52-wk range is $19.54 - 33.48
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
To see all the upgrades/downgrades on shares of ONXX, visit our Analyst Ratings page.
Shares finished trading at $27.68 and the 52-wk range is $19.54 - 33.48
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17
- Barclays Starts Crown Castle (CCI) at Equalweight
- Barclays Starts Verizon Communications (VZ) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Lazard
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
